SCHEMBL6027598

SCHEMBL6027598

Cc1cc(C(F)(F)F)cc(C(=O)O)c1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 2/20 0.55
▸ RXRB P28702 2/20 0.55
▸ TAS2R14 Q9NYV8 2/20 0.49
▸ ACLY P53396 4/20 0.48
▸ TACR1 P25103 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ FABP4 P15090 2/20 0.43
▸ NOTUM Q6P988 2/20 0.43
▸ LDHA P00338 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ RXRG P48443 1/20 0.42
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3905047 0.83 ACLY (0.49) RXRARXRBACLYALDH1A1FABP4
SCHEMBL6637916 0.82 KDM4E (0.47) RXRARXRBTAS2R14ACLYTACR1
SCHEMBL6641662 0.82 TACR1 (0.46) RXRARXRBTAS2R14ACLYTACR1
SCHEMBL27617083 0.79 IGF2BP2 (0.49) FABP4LDHA
SCHEMBL27588778 0.78 TTR (0.53) ALDH1A1FABP4LDHAKDM4E
SCHEMBL11667831 0.78 FABP4 (0.49) ALDH1A1FABP4LDHAKDM4EHPGD
SCHEMBL28588384 0.77 ALDH1A1 (0.43) RXRARXRBTAS2R14ACLYTACR1
SCHEMBL6801907 0.77 RXRA (0.51) RXRARXRBTAS2R14ALDH1A1SMN1; SMN2
SCHEMBL11492330 0.77 FABP4 (0.45) ALDH1A1FABP4LDHAKDM4EHPGD
SCHEMBL135115 0.76 SMO (0.50) RXRARXRBTAS2R14ALDH1A1FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101420949-A Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders NOVARTIS AG (CH) 2009-04-29 — — CN disclosed
EP-1694644-A2 N-ARYL PIPERIDINE SUBSTITUTED BIPHENYLCARBOXAMIDES AS INHIBITORS OF APOLIPOPROTEIN B JANSSEN PHARMACEUTICA N.V. (BE) 2006-08-30 — — EP disclosed
WO-2005058824-A2 N-ARYL PIPERIDINE SUBSTITUTED BIPHENYLCARBOXAMIDES AS INHIBITORS OF APOLIPOPROTE IN B JANSSEN PHARMACEUTICA N.V. (BE) 2005-06-30 — — WO disclosed
EP-1472226-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-03 — — EP disclosed
EP-1383760-A1 BIARYLCARBOXAMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-01-28 — — EP disclosed
WO-2003045921-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-05 — — WO disclosed
WO-2002090347-A1 AMIDE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-14 — — WO disclosed
Send feedback